High-Dose Chemotherapy Plus Non-Cryopreserved Autologous Peripheral Blood Stem Cell Transplantation Rescue for Patients With Refractory or Relapsed Hodgkin Disease-Reference-Cited by-同舟云学术

High-Dose Chemotherapy Plus Non-Cryopreserved Autologous Peripheral Blood Stem Cell Transplantation Rescue for Patients With Refractory or Relapsed Hodgkin Disease

Published:2006-09 Issue:9 Volume:12 Page:942-948
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Mabed Mohamed,Shamaa Sameh

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference33 articles.

1. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin’s disease;Duggan;J Clin Oncol,2003

2. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin’s disease;Diehl;N Engl J Med,2003

3. Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin’s disease;Martin;Br J Haematol,2001

4. Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin’s disease (Croatian experience);Radman;Ann Oncol,2002

5. Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin’s disease;Yahalom;J Clin Oncol,1993

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-cryopreserved Peripheral Stem Cell Autograft for Multiple Myeloma and Lymphoma in Countries with Low Resources;Handbook of Stem Cell Therapy;2022

2. Non-cryopreserved Peripheral Stem Cell Autograft for Multiple Myeloma and Lymphoma in Countries with Low Resources;Handbook of Stem Cell Therapy;2022

3. Clinico-Epidemiological Profile, Prognostic Factors and Treatment Outcome of Refractory Hodgkin Lymphoma;Indian Journal of Hematology and Blood Transfusion;2021-07-03

4. Non-cryopreserved peripheral blood stem cells autologous transplantation in multiple myeloma: Bicentric study;Transfusion Clinique et Biologique;2020-08

5. Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma;memo - Magazine of European Medical Oncology;2020-05-25